aluates Reports

$ 0.0

Automative

Global Rabies Vaccine Market Research Report 2026

Published Date: 2026-01-21

Report Code: QYRE-Auto-34M23

Global Rabies Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Rabies Vaccine Market Research Report 2026

Code: QYRE-Auto-34M23

Report

2026-01-21

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

GSK (Novartis)

Rabies Vaccine Market Size

The global Rabies Vaccine market was valued at US$ 1043 million in 2025 and is anticipated to reach US$ 1367 million by 2032, at a CAGR of 4.0% from 2026 to 2032.

Rabies Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Rabies Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

This report delivers a comprehensive overview of the global Rabies Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Rabies Vaccine. The Rabies Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Rabies Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Rabies Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Rabies Vaccine Market Report

Report Metric	Details
Report Name	Rabies Vaccine Market
Accounted market size in 2025	US$ 1043 million
Forecasted market size in 2032	US$ 1367 million
CAGR	4.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
by Application	Pre-exposure Prophylaxis Post-exposure Prophylaxis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Rabies Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Rabies Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Rabies Vaccine Market growing?

Ans: The Rabies Vaccine Market witnessing a CAGR of 4.0% during the forecast period 2026-2032.

What is the Rabies Vaccine Market size in 2032?

Ans: The Rabies Vaccine Market size in 2032 will be US$ 1367 million.

What is the market share of major companies in Rabies Vaccine Market?

Ans: Global top four manufacturers hold a share about 70%.

What is the Rabies Vaccine Market share by type?

Ans: In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%.

Who are the main players in the Rabies Vaccine Market report?

Ans: The main players in the Rabies Vaccine Market are GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine Market report?

Ans: The Applications covered in the Rabies Vaccine Market report are Pre-exposure Prophylaxis, Post-exposure Prophylaxis

What are the Type segmentation covered in the Rabies Vaccine Market report?

Ans: The Types covered in the Rabies Vaccine Market report are Vero Cell Rabies Vaccine, BHK, Chick Embryo Cell Rabies Vaccine, Others

1 Rabies Vaccine Market Overview

1.1 Product Definition

1.2 Rabies Vaccine by Type

1.2.1 Global Rabies Vaccine Market Value by Type: 2025 vs 2032

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Rabies Vaccine by Application

1.3.1 Global Rabies Vaccine Market Value by Application: 2025 vs 2032

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Global Rabies Vaccine Market Size Estimates and Forecasts

1.4.1 Global Rabies Vaccine Revenue 2021–2032

1.4.2 Global Rabies Vaccine Sales 2021–2032

1.4.3 Global Rabies Vaccine Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Rabies Vaccine Market Competition by Manufacturers

2.1 Global Rabies Vaccine Sales Market Share by Manufacturers (2021–2026)

2.2 Global Rabies Vaccine Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Rabies Vaccine Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Rabies Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Rabies Vaccine, Product Types and Applications

2.7 Global Key Manufacturers of Rabies Vaccine, Date of Entry into the Industry

2.8 Global Rabies Vaccine Market Competitive Situation and Trends

2.8.1 Global Rabies Vaccine Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Rabies Vaccine Players Market Share by Revenue

2.8.3 Global Rabies Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rabies Vaccine Market Scenario by Region

3.1 Global Rabies Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Rabies Vaccine Sales by Region: 2021–2032

3.2.1 Global Rabies Vaccine Sales by Region: 2021–2026

3.2.2 Global Rabies Vaccine Sales by Region: 2027–2032

3.3 Global Rabies Vaccine Revenue by Region: 2021–2032

3.3.1 Global Rabies Vaccine Revenue by Region: 2021–2026

3.3.2 Global Rabies Vaccine Revenue by Region: 2027–2032

3.4 North America Rabies Vaccine Market Facts & Figures by Country

3.4.1 North America Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Rabies Vaccine Sales by Country (2021–2032)

3.4.3 North America Rabies Vaccine Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Rabies Vaccine Market Facts & Figures by Country

3.5.1 Europe Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Rabies Vaccine Sales by Country (2021–2032)

3.5.3 Europe Rabies Vaccine Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rabies Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Rabies Vaccine Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Rabies Vaccine Sales by Region (2021–2032)

3.6.3 Asia Pacific Rabies Vaccine Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rabies Vaccine Market Facts & Figures by Country

3.7.1 Latin America Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Rabies Vaccine Sales by Country (2021–2032)

3.7.3 Latin America Rabies Vaccine Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Rabies Vaccine Sales by Country (2021–2032)

3.8.3 Middle East and Africa Rabies Vaccine Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rabies Vaccine Sales by Type (2021–2032)

4.1.1 Global Rabies Vaccine Sales by Type (2021–2026)

4.1.2 Global Rabies Vaccine Sales by Type (2027–2032)

4.1.3 Global Rabies Vaccine Sales Market Share by Type (2021–2032)

4.2 Global Rabies Vaccine Revenue by Type (2021–2032)

4.2.1 Global Rabies Vaccine Revenue by Type (2021–2026)

4.2.2 Global Rabies Vaccine Revenue by Type (2027–2032)

4.2.3 Global Rabies Vaccine Revenue Market Share by Type (2021–2032)

4.3 Global Rabies Vaccine Price by Type (2021–2032)

5 Segment by Application

5.1 Global Rabies Vaccine Sales by Application (2021–2032)

5.1.1 Global Rabies Vaccine Sales by Application (2021–2026)

5.1.2 Global Rabies Vaccine Sales by Application (2027–2032)

5.1.3 Global Rabies Vaccine Sales Market Share by Application (2021–2032)

5.2 Global Rabies Vaccine Revenue by Application (2021–2032)

5.2.1 Global Rabies Vaccine Revenue by Application (2021–2026)

5.2.2 Global Rabies Vaccine Revenue by Application (2027–2032)

5.2.3 Global Rabies Vaccine Revenue Market Share by Application (2021–2032)

5.3 Global Rabies Vaccine Price by Application (2021–2032)

6 Key Companies Profiled

6.1 GSK (Novartis)

6.1.1 GSK (Novartis) Company Information

6.1.2 GSK (Novartis) Description and Business Overview

6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio

6.1.5 GSK (Novartis) Recent Developments/Updates

6.2 Sanofi-Pasteur

6.2.1 Sanofi-Pasteur Company Information

6.2.2 Sanofi-Pasteur Description and Business Overview

6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio

6.2.5 Sanofi-Pasteur Recent Developments/Updates

6.3 Chengda

6.3.1 Chengda Company Information

6.3.2 Chengda Description and Business Overview

6.3.3 Chengda Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Chengda Rabies Vaccine Product Portfolio

6.3.5 Chengda Recent Developments/Updates

6.4 Yisheng

6.4.1 Yisheng Company Information

6.4.2 Yisheng Description and Business Overview

6.4.3 Yisheng Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Yisheng Rabies Vaccine Product Portfolio

6.4.5 Yisheng Recent Developments/Updates

6.5 Prcmise

6.5.1 Prcmise Company Information

6.5.2 Prcmise Description and Business Overview

6.5.3 Prcmise Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Prcmise Rabies Vaccine Product Portfolio

6.5.5 Prcmise Recent Developments/Updates

6.6 VACN

6.6.1 VACN Company Information

6.6.2 VACN Description and Business Overview

6.6.3 VACN Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 VACN Rabies Vaccine Product Portfolio

6.6.5 VACN Recent Developments/Updates

6.7 Changsheng

6.7.1 Changsheng Company Information

6.7.2 Changsheng Description and Business Overview

6.7.3 Changsheng Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Changsheng Rabies Vaccine Product Portfolio

6.7.5 Changsheng Recent Developments/Updates

6.8 BCHT

6.8.1 BCHT Company Information

6.8.2 BCHT Description and Business Overview

6.8.3 BCHT Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 BCHT Rabies Vaccine Product Portfolio

6.8.5 BCHT Recent Developments/Updates

6.9 Hissen

6.9.1 Hissen Company Information

6.9.2 Hissen Description and Business Overview

6.9.3 Hissen Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Hissen Rabies Vaccine Product Portfolio

6.9.5 Hissen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rabies Vaccine Industry Chain Analysis

7.2 Rabies Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rabies Vaccine Production Mode & Process Analysis

7.4 Rabies Vaccine Sales and Marketing

7.4.1 Rabies Vaccine Sales Channels

7.4.2 Rabies Vaccine Distributors

7.5 Rabies Vaccine Customer Analysis

8 Rabies Vaccine Market Dynamics

8.1 Rabies Vaccine Industry Trends

8.2 Rabies Vaccine Market Drivers

8.3 Rabies Vaccine Market Challenges

8.4 Rabies Vaccine Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

GSK (Novartis)

List of Tables

Table 1. Global Rabies Vaccine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Rabies Vaccine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Rabies Vaccine Market Competitive Situation by Manufacturers in 2025

Table 4. Global Rabies Vaccine Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Rabies Vaccine Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Rabies Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Rabies Vaccine Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Rabies Vaccine, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Rabies Vaccine, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Rabies Vaccine, Product Types and Applications

Table 12. Global Key Manufacturers of Rabies Vaccine, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rabies Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Rabies Vaccine Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Rabies Vaccine Sales by Region (K Units), 2021–2026

Table 18. Global Rabies Vaccine Sales Market Share by Region (2021–2026)

Table 19. Global Rabies Vaccine Sales by Region (K Units), 2027–2032

Table 20. Global Rabies Vaccine Sales Market Share by Region (2027–2032)

Table 21. Global Rabies Vaccine Revenue by Region (US$ Million), 2021–2026

Table 22. Global Rabies Vaccine Revenue Market Share by Region (2021–2026)

Table 23. Global Rabies Vaccine Revenue by Region (US$ Million), 2027–2032

Table 24. Global Rabies Vaccine Revenue Market Share by Region (2027–2032)

Table 25. North America Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Rabies Vaccine Sales by Country (K Units), 2021–2026

Table 27. North America Rabies Vaccine Sales by Country (K Units), 2027–2032

Table 28. North America Rabies Vaccine Revenue by Country (US$ Million), 2021–2026

Table 29. North America Rabies Vaccine Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Rabies Vaccine Sales by Country (K Units), 2021–2026

Table 32. Europe Rabies Vaccine Sales by Country (K Units), 2027–2032

Table 33. Europe Rabies Vaccine Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Rabies Vaccine Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Rabies Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Rabies Vaccine Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Rabies Vaccine Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Rabies Vaccine Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Rabies Vaccine Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Rabies Vaccine Sales by Country (K Units), 2021–2026

Table 42. Latin America Rabies Vaccine Sales by Country (K Units), 2027–2032

Table 43. Latin America Rabies Vaccine Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Rabies Vaccine Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Rabies Vaccine Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Rabies Vaccine Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Rabies Vaccine Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Rabies Vaccine Revenue by Country (US$ Million), 2027–2032

Table 50. Global Rabies Vaccine Sales (K Units) by Type (2021–2026)

Table 51. Global Rabies Vaccine Sales (K Units) by Type (2027–2032)

Table 52. Global Rabies Vaccine Sales Market Share by Type (2021–2026)

Table 53. Global Rabies Vaccine Sales Market Share by Type (2027–2032)

Table 54. Global Rabies Vaccine Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Rabies Vaccine Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Rabies Vaccine Revenue Market Share by Type (2021–2026)

Table 57. Global Rabies Vaccine Revenue Market Share by Type (2027–2032)

Table 58. Global Rabies Vaccine Price (USD/Unit) by Type (2021–2026)

Table 59. Global Rabies Vaccine Price (USD/Unit) by Type (2027–2032)

Table 60. Global Rabies Vaccine Sales (K Units) by Application (2021–2026)

Table 61. Global Rabies Vaccine Sales (K Units) by Application (2027–2032)

Table 62. Global Rabies Vaccine Sales Market Share by Application (2021–2026)

Table 63. Global Rabies Vaccine Sales Market Share by Application (2027–2032)

Table 64. Global Rabies Vaccine Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Rabies Vaccine Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Rabies Vaccine Revenue Market Share by Application (2021–2026)

Table 67. Global Rabies Vaccine Revenue Market Share by Application (2027–2032)

Table 68. Global Rabies Vaccine Price (USD/Unit) by Application (2021–2026)

Table 69. Global Rabies Vaccine Price (USD/Unit) by Application (2027–2032)

Table 70. GSK (Novartis) Company Information

Table 71. GSK (Novartis) Description and Business Overview

Table 72. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 73. GSK (Novartis) Rabies Vaccine Product

Table 74. GSK (Novartis) Recent Developments/Updates

Table 75. Sanofi-Pasteur Company Information

Table 76. Sanofi-Pasteur Description and Business Overview

Table 77. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 78. Sanofi-Pasteur Rabies Vaccine Product

Table 79. Sanofi-Pasteur Recent Developments/Updates

Table 80. Chengda Company Information

Table 81. Chengda Description and Business Overview

Table 82. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 83. Chengda Rabies Vaccine Product

Table 84. Chengda Recent Developments/Updates

Table 85. Yisheng Company Information

Table 86. Yisheng Description and Business Overview

Table 87. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 88. Yisheng Rabies Vaccine Product

Table 89. Yisheng Recent Developments/Updates

Table 90. Prcmise Company Information

Table 91. Prcmise Description and Business Overview

Table 92. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 93. Prcmise Rabies Vaccine Product

Table 94. Prcmise Recent Developments/Updates

Table 95. VACN Company Information

Table 96. VACN Description and Business Overview

Table 97. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 98. VACN Rabies Vaccine Product

Table 99. VACN Recent Developments/Updates

Table 100. Changsheng Company Information

Table 101. Changsheng Description and Business Overview

Table 102. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 103. Changsheng Rabies Vaccine Product

Table 104. Changsheng Recent Developments/Updates

Table 105. BCHT Company Information

Table 106. BCHT Description and Business Overview

Table 107. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 108. BCHT Rabies Vaccine Product

Table 109. BCHT Recent Developments/Updates

Table 110. Hissen Company Information

Table 111. Hissen Description and Business Overview

Table 112. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 113. Hissen Rabies Vaccine Product

Table 114. Hissen Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Rabies Vaccine Distributors List

Table 118. Rabies Vaccine Customers List

Table 119. Rabies Vaccine Market Trends

Table 120. Rabies Vaccine Market Drivers

Table 121. Rabies Vaccine Market Challenges

Table 122. Rabies Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rabies Vaccine

Figure 2. Global Rabies Vaccine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Rabies Vaccine Market Share by Type: 2025 & 2032

Figure 4. Vero Cell Rabies Vaccine Product Picture

Figure 5. BHK Product Picture

Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Rabies Vaccine Market Value by Application (US$ Million), 2021–2032

Figure 9. Global Rabies Vaccine Market Share by Application: 2025 & 2032

Figure 10. Pre-exposure Prophylaxis

Figure 11. Post-exposure Prophylaxis

Figure 12. Global Rabies Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Rabies Vaccine Market Size (US$ Million), 2021–2032

Figure 14. Global Rabies Vaccine Sales (K Units), 2021–2032

Figure 15. Global Rabies Vaccine Average Price (USD/Unit), 2021–2032

Figure 16. Rabies Vaccine Report Years Considered

Figure 17. Rabies Vaccine Sales Share by Manufacturers in 2025

Figure 18. Global Rabies Vaccine Revenue Share by Manufacturers in 2025

Figure 19. Top 5 and Top 10 Global Rabies Vaccine Players: Market Share by Revenue in Rabies Vaccine in 2025

Figure 20. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 21. Global Rabies Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 22. North America Rabies Vaccine Sales Market Share by Country (2021–2032)

Figure 23. North America Rabies Vaccine Revenue Market Share by Country (2021–2032)

Figure 24. U.S. Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Canada Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Europe Rabies Vaccine Sales Market Share by Country (2021–2032)

Figure 27. Europe Rabies Vaccine Revenue Market Share by Country (2021–2032)

Figure 28. Germany Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. France Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. U.K. Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Italy Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Russia Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Asia Pacific Rabies Vaccine Sales Market Share by Region (2021–2032)

Figure 34. Asia Pacific Rabies Vaccine Revenue Market Share by Region (2021–2032)

Figure 35. China Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Japan Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. South Korea Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. India Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Australia Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. China Taiwan Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Indonesia Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Thailand Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Malaysia Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Latin America Rabies Vaccine Sales Market Share by Country (2021–2032)

Figure 45. Latin America Rabies Vaccine Revenue Market Share by Country (2021–2032)

Figure 46. Mexico Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Brazil Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Argentina Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2021–2032)

Figure 50. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2021–2032)

Figure 51. Turkey Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Saudi Arabia Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. UAE Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Global Sales Market Share of Rabies Vaccine by Type (2021–2032)

Figure 55. Global Revenue Market Share of Rabies Vaccine by Type (2021–2032)

Figure 56. Global Rabies Vaccine Price (USD/Unit) by Type (2021–2032)

Figure 57. Global Sales Market Share of Rabies Vaccine by Application (2021–2032)

Figure 58. Global Revenue Market Share of Rabies Vaccine by Application (2021–2032)

Figure 59. Global Rabies Vaccine Price (USD/Unit) by Application (2021–2032)

Figure 60. Rabies Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Rabies Vaccination Market Research Report 2025

Global Human Rabies Vaccine Market Research Report 2024

Global Rabies Vaccine for Pets Market Research Report 2024

Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Anti Rabies Vaccine Market Research Report 2024

Human Rabies Vaccine Vero Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Vaccine Market

Global Rabies Vaccine Antibody Testing Service Market Research Report 2024

Freeze dried Human Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Companion Animals Rabies Veterinary Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Passive Immunizing Drugs against Rabies Market Research Report 2024

Rabies Virus Vaccine for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Vaccination Market Research Report 2025

Global Livestock Animal Vaccines Market Research Report 2024

Global Livestock Animal Vaccination Market Research Report 2025

Global Rabies Virus Monoclonal Antibody Market Research Report 2024

Global Rabies Antiserum Market Research Report 2024

Global Human Rabies Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions